Introductory comments about the special series of thrombotic microangiopathy.
作者信息
Zheng X Long
机构信息
Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS, USA.
出版信息
Ann Blood. 2024 Jun 30;9. doi: 10.21037/aob-24-6. Epub 2024 Apr 1.
Abstract
摘要
相似文献
1
Introductory comments about the special series of thrombotic microangiopathy.关于血栓性微血管病专题系列的引言性评论。
Ann Blood. 2024 Jun 30;9. doi: 10.21037/aob-24-6. Epub 2024 Apr 1.
2
Recent advances in thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的最新进展
Hematology Am Soc Hematol Educ Program. 2004:407-23. doi: 10.1182/asheducation-2004.1.407.
3
Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.急性相时 von Willebrand 因子高分子多聚体的丢失与获得性血栓性血小板减少性紫癜中可检测到的抗 ADAMTS13 IgG 和神经症状相关。
Thromb Res. 2019 Sep;181:29-35. doi: 10.1016/j.thromres.2019.07.012. Epub 2019 Jul 16.
4
An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜发病机制和诊断的研究进展。
Expert Rev Hematol. 2019 Jun;12(6):383-395. doi: 10.1080/17474086.2019.1611423. Epub 2019 May 20.
5
The role of von Willebrand factor in thrombotic microangiopathy.血管性血友病因子在血栓性微血管病中的作用。
Pediatr Nephrol. 2018 Aug;33(8):1297-1307. doi: 10.1007/s00467-017-3744-y. Epub 2017 Jul 26.
6
Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.纤维蛋白溶酶对血管性血友病因子的裂解作用可作为血栓性微血管病中 ADAMTS13 缺乏症的紧急旁路。
Circulation. 2014 Mar 25;129(12):1320-31. doi: 10.1161/CIRCULATIONAHA.113.006727. Epub 2014 Jan 21.
7
von Willebrand factor and thrombotic thrombocytopenic purpura.血管性血友病因子与血栓性血小板减少性紫癜
Curr Opin Hematol. 2000 Sep;7(5):278-83. doi: 10.1097/00062752-200009000-00004.
8
[From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].从基因到疾病；因ADAMTS13基因突变导致的先天性血栓性血小板减少性紫癜
Ned Tijdschr Geneeskd. 2003 Dec 6;147(49):2422-4.
9
Pediatric thrombotic thrombocytopenic purpura.小儿血栓性血小板减少性紫癜。
Eur J Haematol. 2018 Oct;101(4):425-434. doi: 10.1111/ejh.13107. Epub 2018 Aug 22.
10
Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients.在危重症 COVID-19 患者中，血管性血友病因子（von Willebrand factor）与 ADAMTS13 轴的失衡与其说是血栓形成过程的原因，不如说是强烈炎症和内皮损伤的生物标志物。
J Thromb Haemost. 2021 Sep;19(9):2193-2198. doi: 10.1111/jth.15445. Epub 2021 Jul 27.
本文引用的文献
1
The history of thrombotic thrombocytopenic purpura research: a narrative review.血栓性血小板减少性紫癜研究史：一项叙述性综述。
Ann Blood. 2024 Jun 30;9. doi: 10.21037/aob-23-46. Epub 2024 Feb 16.
2
How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura?卡泊西单抗应如何用于治疗免疫性血栓性血小板减少性紫癜？
Ann Blood. 2023 Jun 30;8. doi: 10.21037/aob-21-87. Epub 2022 Apr 1.
3
Mechanisms of inhibition of human monoclonal antibodies in immune thrombotic thrombocytopenic purpura.人类单克隆抗体在免疫性血栓性血小板减少性紫癜中的抑制机制。
Blood. 2023 Jun 15;141(24):2993-3005. doi: 10.1182/blood.2022019252.
4
Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura.自身抗体增强免疫性血栓性血小板减少性紫癜患者 ADAMTS-13 的清除。
J Thromb Haemost. 2023 Jun;21(6):1544-1552. doi: 10.1016/j.jtha.2023.02.011. Epub 2023 Feb 20.
5
Recombinant ADAMTS13 in Severe Neonatal Thrombotic Thrombocytopenic Purpura.重组ADAMTS13在重症新生儿血栓性血小板减少性紫癜中的应用
N Engl J Med. 2022 Dec 22;387(25):2391-2392. doi: 10.1056/NEJMc2210781.
6
Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura.遗传性血栓性血小板减少性紫癜的重组 ADAMTS13。
N Engl J Med. 2022 Dec 22;387(25):2356-2361. doi: 10.1056/NEJMoa2211113.
7
The standard of care for immune thrombotic thrombocytopenic purpura today.目前免疫性血栓性血小板减少性紫癜的治疗标准。
J Thromb Haemost. 2021 Aug;19(8):1864-1871. doi: 10.1111/jth.15406. Epub 2021 Jun 30.
8
Characterization and treatment of congenital thrombotic thrombocytopenic purpura.先天性血栓性血小板减少性紫癜的特征与治疗。
Blood. 2019 Apr 11;133(15):1644-1651. doi: 10.1182/blood-2018-11-884700. Epub 2019 Feb 15.
9
ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw-Schulman Syndrome.ADAMTS13 基因突变影响法国 Upshaw-Schulman 综合征队列中 ADAMTS13 构象和发病年龄。
Thromb Haemost. 2018 Nov;118(11):1902-1917. doi: 10.1055/s-0038-1673686. Epub 2018 Oct 12.
10
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.重组ADAMTS-13：先天性血栓性血小板减少性紫癜的首次人体药代动力学和安全性研究
Blood. 2017 Nov 9;130(19):2055-2063. doi: 10.1182/blood-2017-06-788026. Epub 2017 Sep 14.
Zotero 插件